Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Induction Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan) Followed by Short Course Radiotherapy in Locally Advanced Rectal Cancer

NCT05868317 is registered in ClinicalTrials.gov with Salah Azaïz Cancer Institute as lead sponsor.

NCT NCT05868317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05868317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Induction Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan) Followed by Short Course Radiotherapy in Locally Advanced Rectal Cancer
Lead sponsor
Salah Azaïz Cancer Institute
Phase
Phase 2
Overall status
Unknown status
Start date
November 1, 2020
Completion date
November 30, 2023
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced, rectal cancer